Modulation of the toxicity and antitumour activity of alkylating drugs by steroids
Open Access
- 1 March 1982
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 45 (3) , 413-420
- https://doi.org/10.1038/bjc.1982.69
Abstract
The steroids prednisolone and progesterone significantly altered the therapeutic indices of the alkylating agents, nitrogen mustard, melphalan, cyclophosphamide, phenyl acetic mustard and chlorambucil. For nitrogen mustard, chlorambucil and phenyl acetic mustard, prednisolone reduced host toxicity in the rat and enhanced the antitumour effectiveness against alkylating-agent-resistant strains of the Yoshida sarcoma and Walker carcinosarcoma. Progesterone also increased the therapeutic index of chlorambucil in the rat by decreasing its systemic toxicity. Two other alkylating agents, melphalan and cyclophosphamide, exhibited lower therapeutic indices in combination with prednisolone against alkylating-agent-sensitive tumours. This was due to the greater host toxicity of the combination than of the alkylating agent alone. In alkylating-agent-resistant tumours, however, a significant increase in growth delay was achieved if prednisolone was combined with the alkylating agent.Keywords
This publication has 40 references indexed in Scilit:
- Chlorambucil vs. combined chlorambucil-corticosteroid therapy in chronic lymphocytic leukemiaCancer, 1973
- New platinum complexes with anti-tumour activityChemico-Biological Interactions, 1972
- Cyclophosphamide (NSC-26271), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) (COAP) combination chemotherapy for acute leukemia in adults.1972
- Modification of the alkylating ability of cyclophosphamide by fresh plasmaChemico-Biological Interactions, 1972
- Relapse patterns in Burkitt's lymphoma.1972
- Thymus-Derived Lymphocytes Sequestered in the Bone Marrow of Hydrocortisone-Treated MiceThe Journal of Immunology, 1972
- Factors determining cell killing by chemotherapeutic agents In Vivo—II.: Melphalan, chlorambucil and nitrogen mustardPublished by Elsevier ,1971
- The selectivity of action of alkylating agents and drug resistance. II. A comparison of the effects of alkylating drugs on growth inhibition and cell size in sensitive and resistant strains of the Yoshida ascites sarcoma.British Journal of Cancer, 1969
- Preliminary trials with combination therapy of cyclophosphamide (NSC-26271), vincristine (NSC-67574), and 5-fluorouracil (NSC-19893).1968
- WALKER CARCINOSARCOMA 256 IN STUDY OF ANTICANCER AGENTS .I. METHOD FOR SIMULTANEOUS ASSESSMENT OF THERAPEUTIC VALUE AND TOXICITY1966